TOLIENT Trademark

Trademark Overview


On Friday, February 3, 2017, a trademark application was filed for TOLIENT with the United States Patent and Trademark Office. The USPTO has given the TOLIENT trademark a serial number of 87323333. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 30, 2018. This trademark is owned by Eli Lilly and Company. The TOLIENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
tolient

General Information


Serial Number87323333
Word MarkTOLIENT
Filing DateFriday, February 3, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 30, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 30, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 30, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 28, 2017EXTENSION 1 GRANTED
Tuesday, November 21, 2017EXTENSION 1 FILED
Monday, November 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 21, 2017TEAS EXTENSION RECEIVED
Tuesday, June 27, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 2, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 18, 2017ASSIGNED TO EXAMINER
Wednesday, February 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 7, 2017NEW APPLICATION ENTERED IN TRAM